Contemporary Incidence and Predictors of Major Adverse Cardiac Events After Saphenous Vein Graft Intervention With Embolic Protection (an AMEthyst Trial Substudy)

Dec 23, 2016 by in CARDIOLOGY Comments Off on Contemporary Incidence and Predictors of Major Adverse Cardiac Events After Saphenous Vein Graft Intervention With Embolic Protection (an AMEthyst Trial Substudy)

The incidence and predictors of major adverse cardiac events after percutaneous coronary intervention of saphenous vein grafts have not been evaluated in the era of routine embolic protection device (EPD)…

read more

Comparison of Bivalirudin and Unfractionated Heparin Plus Protamine in Patients With Coronary Heart Disease Undergoing Percutaneous Coronary Intervention (from the Antithrombotic Regimens aNd Outcome [ARNO] Trial)

Dec 23, 2016 by in CARDIOLOGY Comments Off on Comparison of Bivalirudin and Unfractionated Heparin Plus Protamine in Patients With Coronary Heart Disease Undergoing Percutaneous Coronary Intervention (from the Antithrombotic Regimens aNd Outcome [ARNO] Trial)

Previous studies have compared bivalirudin and unfractionated heparin (UFH) plus the routine use of glycoprotein IIb/IIIa inhibitors. They have demonstrated that bivalirudin can decrease bleeding complications without a significant increase…

read more

Comparison of the Usefulness of N-Terminal Pro-Brain Natriuretic Peptide to Other Serum Biomarkers as an Early Predictor of ST-Segment Recovery After Primary Percutaneous Coronary Intervention

Dec 23, 2016 by in CARDIOLOGY Comments Off on Comparison of the Usefulness of N-Terminal Pro-Brain Natriuretic Peptide to Other Serum Biomarkers as an Early Predictor of ST-Segment Recovery After Primary Percutaneous Coronary Intervention

Data on the ability of serum biomarkers to predict microvascular obstruction by ST-segment recovery after primary percutaneous coronary intervention (PCI) is largely absent. Therefore, we determined the association between 5…

read more
Get Clinical Tree app for offline access